India’s Bioeconomy Reaches $165 Billion Milestone; Dr. Jitendra Singh Launches Bio-Sarthi & BioEconomy Report
New Delhi, March 2025- As a milestone in the biotechnology sector, India has achieved an estimated bioeconomy of approximately $165 billion. An ecosystem of 10,000 biotech startups catalyzes the drastic change. Union Minister of State for Science and Technology Dr. Jitendra Singh made this very important proclamation during the celebration of the 13th Biotechnology Industry Research Assistance Council (BIRAC) Foundation Day.
In that regard, the minister stated that India was now a global player in biotechnology and space research, making all government commitments to strengthening science, technology, and innovation available. He also noted that the biotech sector in India has become one of the key pillars in transforming the economic landscape through job creation and scientific breakthroughs/technological innovations.
Pioneering Space Medicine & Biotech Advancements
As Dr. Jitendra Singh also mentioned, the efforts made in India since the beginning of space medicine are considered pioneering, with India being one of the first to explore this domain. He mentioned that the Department of Biotechnology, which had worked in collaboration with ISRO, has helped take research and innovation in this area ahead by leaps and bounds.
He also highlighted the importance of India’s ground-breaking developments in biotechnology, especially in the vaccine development research sector. During the COVID-19 pandemic, India has shown promising results by developing the vaccine and can become a successful global leader in vaccine manufacturing. He also highlighted the advancements in developing vaccines against multiple diseases such as tuberculosis, malaria, and hemophilia. This also portrays that in the future, India will ensure its influence in the international health sector.
Launch of Bio-Sarthi: A New Era of Biotech Mentorship
The launch of Bio-Sarthi was one of the highlights of the event. The international mentoring program will connect emerging biotech entrepreneurs with industry professionals, policymakers, and investors. As a wave of biotech startups expands in India, mentorship and guidance will be the vital few things ensuring their success in navigating the regulatory, funding, and innovation challenges.
Bio-Sarthi is poised to spur innovation, promote knowledge sharing, and speed up the growth of startups to the bioeconomy of India.
India BioEconomy Report 2025: A Blueprint for Growth
Dr. Singh also revealed the much-anticipated India BioEconomy Report 2025, a yearly publication by the Department of Biotechnology and BIRAC. This report serves as a comprehensive synopsis of India’s bioeconomy.
The report is an essential resource for researchers, startups, investors, and policymakers, offering a strategically planned roadmap for the future of India’s biotechnology sector.
BIRAC’s 13-Year Legacy of Driving Biotech Innovation
Dr. Jitendra Singh also congratulated BIRAC on its 13th anniversary, praising their efforts in funding and supporting multiple biotech research and startups. Since, BIRAC was founded, it has played an important role in nurturing India’s biotech ecosystem, enabling cutting-edge research, entrepreneurship, and commercialization of biotech innovations.
A Bright Future for India’s Bioeconomy
With the support of government-backed initiatives, strong industry-academia collaborations, and a surge in biotech entrepreneurship, India’s bioeconomy is set to witness unprecedented growth in the coming years.
The $165 billion milestone is not just a number but represents the commitment of India for scientific excellence, global leadership in biotech, and a future that is driven by innovation.
The launch of Bio-Sarthi and the India BioEconomy Report 2025 are strategic steps toward making sure that India’s biotech revolution will continue to thrive, making way for pathbreaking discoveries, robust investments, and global influence in biotechnology and healthcare.
As India has confirms its position as a biotech powerhouse, initiatives like Bio-Sarthi and reports like India BioEconomy Report 2025 will be playing a pivotal role in shaping the industry’s trajectory.
The upcoming future of India’s bioeconomy looks quite promising, with unbelievable innovation, investment, and worldwide recognition driving its continued success.
With the government’s unwavering support and a thriving startup ecosystem, India’s biotech sector is well on its way to becoming a $300 billion industry in the coming years.
India’s Bioeconomy Reaches $165 Billion Milestone; Dr. Jitendra Singh Launches Bio-Sarthi & BioEconomy Report
